The usefulness of L-carnitine supplementation in hemodialysis patients

The usefulness of L-carnitine supplementation in hemodialysis patients - The usefulness of L-carnitine supplementation in hemodialysis patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012222

Enrollment

100

Registered

2013-11-06

Start date

2013-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patients (chronic kidney disease)

Interventions

(1) Intravenous L-carnitine 20 mg/kg administration after each hemodialysis for 6 months (2) Wash out for 3months (3) Intravenous saline administration after each hemodialysis for 6months (1) Intrav

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: hemodialisys patients

Exclusion criteria

Exclusion criteria: Patients known to have a history of complication or allergy to L-carnitine. Women who are pregnant or possibly pregnant. Patients who are judged to be inappropriate to this study.

Design outcomes

Primary

Measure	Time frame
improvement of cardiac function, anemia and exercise tolerance	—

Countries

Japan

Contacts

Public ContactYusuke Kobayashi

Yokosuka city hospital Department of nephrology

yusuke.kob@live.jp046-856-3136

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026